A Single and Multiple Ascending Dose Trial of KT-474 in Healthy Adult Volunteers and Patients With Atopic Dermatitis (AD) or Hidradenitis Suppurativa (HS)

NCT04772885 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

154

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer
Atopic Dermatitis
Hidradenitis Suppurativa

Interventions

DRUG: KT-474/Placebo
DRUG: KT-474

Sponsor

Kymera Therapeutics, Inc.